Clicky

Tuesday, October 27, 2026

Companies

Public company updates

Capstone Energy Plus appoints Brandon Schwertner to Board

Capstone Energy Plus, Inc. has appointed Brandon Schwertner to its Board of Directors, enhancing leadership as it aims for growth in the energy sector.

Bank of Hawaii reports solid Q3 results, boosts buyback program

Bank of Hawaii Corp announces Q3 earnings of $1.49 per share and increases share repurchase program by $200 million, reflecting strong financial performance.

LiveWire Group Announces CEO Resignation, Board Changes

LiveWire Group, Inc. announces CEO resignation and new board appointments as part of a strategic restructuring effort.

Empery Digital Resumes Stock Buyback Program Amid Updates

Empery Digital Inc. resumes its stock repurchase program and announces plans for an AI data center investment, signaling a strategic shift in capital allocation.

Business First Bancshares announces Q3 results and dividends

Business First Bancshares reports strong Q3 results with increased net income and dividends, reflecting growth in the state commercial banking sector.

SHF Holdings announces potential merger with Opifex Media

SHF Holdings, Inc. reveals a potential business combination with Opifex Media Inc., a significant move in the finance services sector.

K&F Growth Acquisition Corp. II Issues Class A Shares

K&F Growth Acquisition Corp. II has issued 9,583,332 Class A shares, moving towards a business combination and impacting the blank check industry.

Medifast Reports Third Quarter Earnings Decline Amid Challenges

Medifast, Inc. faces a revenue drop in Q3 2026, driven by fewer active coaches and market pressures, as it aims for profitability in the next quarter.

Valion Bio Receives Acquisition Interest for Velocity Bioworks

Valion Bio, Inc. announces unsolicited acquisition interest in its Velocity Bioworks subsidiary, evaluating strategic options for growth and development.

SpaceX Enters $40 Billion Finance Lease with Apollo Management

SpaceX has entered a master finance lease with Apollo Global Management for $40 billion, aimed at enhancing its data center capabilities.

Oruka Therapeutics reports positive Phase 2b trial results

Oruka Therapeutics announces encouraging results from its Phase 2b trial of ORKA-001 for psoriasis, paving the way for Phase 3 trials in 2027.

Zeo ScientifiX Partners with Pluri to Expand Manufacturing

Zeo ScientifiX announces a strategic partnership with Pluri Inc. to enhance U.S. manufacturing and commercialization in regenerative medicine and aesthetics.

Getty Images Files for Chapter 11 Bankruptcy Protection

Getty Images Holdings, Inc. has filed for Chapter 11 bankruptcy, seeking to restructure its debts with up to $143 million in financing.

Braemar Hotels & Resorts nominates eight for board election

Braemar Hotels & Resorts Inc. announces nomination of eight new directors to strengthen leadership amid competitive real estate investment trust sector.

Cyber Enviro-Tech Amends Equity Purchase Agreement with Investor

Cyber Enviro-Tech, Inc. modifies its equity purchase agreement, allowing for a more flexible pricing structure to enhance capital-raising capabilities.

Oaktree Acquisition Corp. III Life Sciences extends business deadline

Oaktree Acquisition Corp. III Life Sciences extends its deadline to complete a business combination to November 25, 2026, impacting its strategic direction.

Phathom Pharmaceuticals Responds to FDA Docket on VOQUEZNA

Phathom Pharmaceuticals reacts to FDA's public docket on VOQUEZNA's exclusivity, amid ongoing litigation with BDR Pharmaceuticals.

Elme Communities to Delist from NYSE Amid Liquidation Plans

Elme Communities is set to delist from the NYSE due to low stock prices and will begin trading OTC as it moves forward with liquidation plans.

Bio Essence Corp adds new directors, amends bylaws

Bio Essence Corp appoints Thea Zhang and Geoff Fellows to its board, expanding governance and operational capabilities while amending bylaws for a larger board.

Eikon Therapeutics presents clinical data at oncology congress

Eikon Therapeutics shares promising clinical data from its PARP1 and WRN helicase programs at the European Society for Medical Oncology Congress.

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →